REQUEST A DEMO
Total
USD $0.00
Search more companies

Pantson Pharma Private Limited (India)

Main Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Pantson Pharma Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pantson Pharma Private Limited is an unlisted company, incorporated on 20/09/2012. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U74120MH2012PTC235942 and registration number is 235942. The company is a professional, scientific and technical company, it is engaged in scientific research and development.

Legal Address
A-63, Ttc Industrial Area, Midc, Khairane,
Thane; Maharashtra; Postal Code: 400705

Contact Details: Purchase the Pantson Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Pantson Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Pantson Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Pantson Pharma Private Limited report to view the information.
Incorporation Date:
September 20, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
50%
Subsidiaries
Rinica Pharma Private Limited
75%
Company Performance
Financial values in the chart are available after Pantson Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.22%
Total operating revenue
0.47%
Operating profit (EBIT)
-29.13%
EBITDA
-11.8%
Net Profit (Loss) for the Period
-29.76%
Total assets
21.02%
Total equity
45.98%
Operating Profit Margin (ROS)
-5.97%
Net Profit Margin
-4.6%
Return on Equity (ROE)
-34.66%
Debt to Equity Ratio
50.3%
Quick Ratio
0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?